Telesis Bio Inc.
TBIO Healthcare Medical Devices
Revenue growth for five consecutive years, operating cash flow growth for three.
Follow TBIO
Telesis Bio Inc. (TBIO) EV/Sales
As of 15 October 2026, Telesis Bio Inc. (TBIO) trades at a EV/Sales of 0.1×. Over the past ten years it has ranged from −2.5× (September 2021) to 26.4× (October 2021); the current reading is higher than 36% of that period. That is below the Medical Devices industry median of 2.2× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2023 | −0.1× | — |
| FY2022 | 0.5× | (95.52%) |
| FY2021 | 11.6× | (39.74%) |
| FY2020 | 19.3× | 0.00% |
| FY2020 | 19.3× | 0.00% |
| FY2019 | 19.3× | 0.00% |
| FY2019 | 19.3× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Sep 2024 | 0.5× | 455.05% |
| Jun 2024 | 0.1× | (18.53%) |
| Mar 2024 | 0.1× | — |
| Dec 2023 | −0.1× | — |
| 14 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| NVNO enVVeno Medical Corporation compare | −63.5× |
| CODX Co-Diagnostics, Inc. compare | −1.2× |
| AMIX Autonomix Medical, Inc. compare | n/m |
| WOK WORK Medical Technology Group LTD compare | n/m |
| TBIO Telesis Bio Inc. | 0.1× |
| INBS Intelligent Bio Solutions Inc. compare | 0.2× |
| VVOS Vivos Therapeutics, Inc. compare | 0.4× |
| TRIB Trinity Biotech PLC compare | 3.0× |
| VNRX VolitionRX Limited compare | 4.0× |
| Medical Devices industry median | 2.2× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)